Published in Int J Colorectal Dis on July 29, 2010
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) (2013) 1.08
Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis. Surg Endosc (2012) 1.00
Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97
Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis (2011) 0.93
Colorectal liver metastases. Int J Surg Oncol (2011) 0.93
Timing of hepatectomy for resectable synchronous colorectal liver metastases: for whom simultaneous resection is more suitable--a meta-analysis. PLoS One (2014) 0.88
Simultaneous laparoscopic resection of primary colorectal cancer and associated liver metastases: a systematic review. Tech Coloproctol (2013) 0.87
Laparoscopic Simultaneous Resection of Colorectal Primary Tumor and Liver Metastases: Results of a Multicenter International Study. World J Surg (2015) 0.83
Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg (2011) 0.80
Short-term outcomes of simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastases. Int Surg (2014) 0.77
Treatment strategy for colorectal cancer with resectable synchronous liver metastases: Is any evidence-based strategy possible? World J Hepatol (2012) 0.76
I BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 2: APPROACH TO RESECTABLE METASTASES. Arq Bras Cir Dig (2016) 0.75
Posthepatectomy liver failure after simultaneous versus staged resection of colorectal cancer and synchronous hepatic metastases. G Chir (2014) 0.75
Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives. Visc Med (2016) 0.75
Laparoscopic combined colorectal and liver resections for primary colorectal cancer with synchronous liver metastases. Ann Hepatobiliary Pancreat Surg (2016) 0.75
Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer. Surgery (2016) 0.75
Therapeutic strategies for synchronous and multiple liver metastases from colorectal cancer. Oncol Rev (2012) 0.75
Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol (2016) 0.75
Simultaneous resection of primary colorectal cancer and synchronous liver metastases: a population-based study. Can J Surg (2017) 0.75
Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group. Ecancermedicalscience (2017) 0.75
Laparoscopic simultaneous resection of colorectal primary tumor and liver metastases: a propensity score matching analysis. Surg Endosc (2015) 0.75
Contemporary surgical management of synchronous colorectal liver metastases. F1000Res (2017) 0.75
Intermittent clamping of the hepatic pedicle in simultaneous ultrasonography-guided liver resection and colorectal resection with intestinal anastomosis: is it safe? Int J Colorectal Dis (2014) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol (2005) 10.99
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery (1991) 3.35
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer (2006) 3.26
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol (2007) 2.26
Resection of liver metastases in colorectal cancer--competitive analysis of treatment results in synchronous versus metachronous metastases. Eur J Surg Oncol (1990) 2.07
Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg (2003) 2.06
Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg (2007) 1.70
Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg (2000) 1.62
Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model. Ann Surg Oncol (2007) 1.61
Hepatic resection for metastatic colorectal cancer. Am Surg (1997) 1.55
Hepatectomy for liver metastases. Br J Surg (1993) 1.50
Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet (1970) 1.48
Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery (2004) 1.30
Is simultaneous hepatectomy and intestinal anastomosis safe? Am J Surg (1995) 1.29
Bringing it all together: Lancet-Cochrane collaborate on systematic reviews. Lancet (2001) 1.28
Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg (2003) 1.26
Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg (2009) 1.23
Major liver resections synchronous with colorectal surgery. Ann Surg Oncol (2007) 1.21
Resection of synchronous liver metastases from colorectal cancer. World J Surg (1991) 1.15
Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol (2001) 1.14
Simultaneous versus staged liver resection of synchronous liver metastases from colorectal cancer. Int J Colorectal Dis (2007) 1.13
Resection and embolization in the management of secondary hepatic tumors. World J Surg (1982) 1.11
Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum (2004) 1.09
Strategies for the treatment of synchronous liver metastasis. Eur J Surg Oncol (2007) 1.03
[Surgical strategy in the treatment of synchronous hepatic metastases of colorectal cancers. Analysis of a series of 59 operated on patients]. Chirurgie (1999) 0.96
Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol (2000) 0.93
Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital. Int J Colorectal Dis (1991) 0.92
Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations. World J Gastroenterol (2007) 0.89
Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference? J Gastrointest Surg (2008) 0.86
Synchronous resection of colorectal primary cancer and liver metastases. World J Surg (2007) 0.84
[Surgical treatment of synchronous hepatic metastases of colorectal cancers. Simultaneous or delayed resection?]. Ann Chir (1996) 0.80
Metastatic patterns in patients with carcinomas of the lower esophagus and upper rectum. Invasion Metastasis (1984) 0.79
Outcomes of simultaneous and delayed resections of synchronous colorectal liver metastases. Can J Surg (2009) 0.79
MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res (2011) 1.80
Prognostic role of microRNA-100 in various carcinomas: evidence from six studies. Tumour Biol (2013) 1.47
miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet (2011) 1.41
Preoperative serum soluble receptor activator of nuclear factor-κB ligand and osteoprotegerin predict postoperative atrial fibrillation in patients undergoing cardiac valve surgery. Ann Thorac Surg (2013) 1.40
Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases. J Surg Oncol (2010) 1.35
Inertial sensor-based methods in walking speed estimation: a systematic review. Sensors (Basel) (2012) 1.33
Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol (2010) 1.32
Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci (2010) 1.29
Concurrent validation of Xsens MVN measurement of lower limb joint angular kinematics. Physiol Meas (2013) 1.18
The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients. PLoS One (2011) 1.16
Prognostic significance of tumor size in T3 gastric cancer. Ann Surg Oncol (2009) 1.10
Mitral valve replacement through a minimal right vertical infra-axillary thoracotomy versus standard median sternotomy. Ann Thorac Surg (2009) 1.09
Estimation of spatio-temporal parameters for post-stroke hemiparetic gait using inertial sensors. Gait Posture (2012) 1.05
pH dependence of light-driven proton pumping by an archaerhodopsin from Tibet: comparison with bacteriorhodopsin. Biophys J (2006) 1.04
Ventricular septal defects closure using a minimal right vertical infraaxillary thoracotomy: seven-year experience in 274 patients. Ann Thorac Surg (2010) 1.03
Dermatofibrosarcoma protuberans: clinical diagnoses and treatment results of 260 cases in China. J Surg Oncol (2011) 1.01
PGC-1alpha inhibits oleic acid induced proliferation and migration of rat vascular smooth muscle cells. PLoS One (2007) 0.96
The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). J Surg Oncol (2008) 0.95
Comparison between single-incision and conventional three-port laparoscopic appendectomy: a meta-analysis from eight RCTs. Int J Colorectal Dis (2013) 0.95
Predicting chemosensitivity in osteosarcoma prior to chemotherapy: An investigational study of biomarkers with immunohistochemistry. Oncol Lett (2012) 0.94
Stem-cell-capturing collagen scaffold promotes cardiac tissue regeneration. Biomaterials (2011) 0.92
A concurrent comparison of inertia sensor-based walking speed estimation methods. Conf Proc IEEE Eng Med Biol Soc (2011) 0.89
Ambulatory running speed estimation using an inertial sensor. Gait Posture (2011) 0.89
The use of unilateral or bilateral external oblique myocutaneous flap in the reconstruction of lower abdominal wall or groin defects after malignant tumor resection. J Surg Oncol (2014) 0.88
Poor prognostic factors in patients with stage I gastric cancer according to the seventh edition TNM classification: a comparative analysis of three subgroups. J Surg Oncol (2011) 0.88
The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression. Ann Surg Oncol (2010) 0.87
Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation. Int J Cardiol (2011) 0.86
stx2vha is the dominant genotype of Shiga toxin-producing Escherichia coli O157:H7 isolated from patients and domestic animals in three regions of China. Microbiol Immunol (2005) 0.86
Prognostic factors in patients with node-negative gastric cancer: a single center experience from China. J Gastrointest Surg (2012) 0.86
Defining a high-risk subgroup of pathological T2N0 gastric cancer by prognostic risk stratification for adjuvant therapy. J Gastrointest Surg (2011) 0.86
The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients. J Surg Oncol (2012) 0.85
FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer. Immunol Res (2015) 0.83
Prognostic significance of c-erbB-2 and vascular endothelial growth factor in colorectal liver metastases. Ann Surg Oncol (2010) 0.82
[Study on diarrhea disease caused by enterohemorrhagic Escherichia coli O157:H7 in Xuzhou city, Jiangsu province in 2000]. Zhonghua Liu Xing Bing Xue Za Zhi (2002) 0.81
Isolation of Escherichia coli O157:H7 from dung beetles Catharsius molossus. Microbiol Immunol (2003) 0.81
The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma. Oncologist (2014) 0.81
Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. Int J Colorectal Dis (2008) 0.81
Imatinib as preoperative therapy in Chinese patients with recurrent or metastatic GISTs. Chin J Cancer Res (2013) 0.80
Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients. Medicine (Baltimore) (2015) 0.80
Higher FOXP3-TSDR demethylation rates in adjacent normal tissues in patients with colon cancer were associated with worse survival. Mol Cancer (2014) 0.79
Inertial sensors in estimating walking speed and inclination: an evaluation of sensor error models. Med Biol Eng Comput (2012) 0.79
LC-MS/MS determination of pogostone in rat plasma and its application in pharmacokinetic studies. Biomed Chromatogr (2013) 0.78
Measurement of lower limb joint kinematics using inertial sensors during stair ascent and descent in healthy older adults and stroke survivors. J Healthc Eng (2013) 0.78
Solitary lymph node metastasis is a distinct subset of colon cancer associated with good survival: a retrospective study of surveillance, epidemiology, and end-results population-based data. BMC Cancer (2014) 0.77
[Serological investigations on patients with hemolytic uremic syndromes due to enterohemorrhagic Escherichia coli O157:H7 infection]. Zhonghua Liu Xing Bing Xue Za Zhi (2002) 0.77
Hypoxia-inducible factor-1α C1772T polymorphism and cancer risk: a meta-analysis including 18,334 subjects. Cancer Invest (2014) 0.77
Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients. J Surg Oncol (2012) 0.76
Imatinib mesylate treatment for a Chinese patient with metastatic and recurrent dermatofibrosarcoma protuberans: is sustained partial remission possible? Eur J Cancer Prev (2012) 0.76
Triton X-100 can alter the temporal sequence of the light-driven proton pump of archaerhodopsin 4. FEBS Lett (2006) 0.75
Timing of resection for colorectal primary cancer and synchronous liver metastases. Dig Dis Sci (2010) 0.75
An urgent need to develop novel markers for prognosis in colon cancer. J Surg Oncol (2010) 0.75
Impact of Age on the Prognosis of Operable Gastric Cancer Patients: An Analysis Based on SEER Database. Medicine (Baltimore) (2016) 0.75
Laparoscopic Low Anterior Resection and Eversion Technique Combined With a Nondog Ear Anastomosis for Mid- and Distal Rectal Neoplasms: A Preliminary and Feasibility Study. Medicine (Baltimore) (2015) 0.75
Predicting individual prognosis for patients undergoing resection of colorectal liver metastases. Ann Surg Oncol (2010) 0.75
Accelerate farmer's agricultural S&T training in Tibet. Environ Sci Technol (2014) 0.75
Intelligent control of a smart walker and its performance evaluation. IEEE Int Conf Rehabil Robot (2013) 0.75
IMU-based ambulatory walking speed estimation in constrained treadmill and overground walking. Comput Methods Biomech Biomed Engin (2011) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
China’s carbon trading scheme is a priority. Environ Sci Technol (2014) 0.75
Gene symbol: hMSH2. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Lower-limb-driven energy harvesting: preliminary analysis. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Mechanical energy transfers across lower limb segments during stair ascent and descent in young and healthy older adults. Gait Posture (2011) 0.75
Wearable Sensor-Based Sign Language Recognition: A Comprehensive Review. IEEE Rev Biomed Eng (2020) 0.75
Gene symbol: hMSH2. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Development of an energy harvesting backpack and performance evaluation. IEEE Int Conf Rehabil Robot (2013) 0.75
Reshaping China's nuclear energy policy. Environ Sci Technol (2011) 0.75
Gene symbol: hMSH2. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Dispersion-optimized optical fiber for high-speed long-haul dense wavelength division multiplexing transmission. Appl Opt (2011) 0.75
[Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): Chinese subgroup analysis]. Zhonghua Wei Chang Wai Ke Za Zhi (2014) 0.75
Gene symbol: hMSH2. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMSH. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMSH2. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Investigation of a passive inter-limb device on step-to-step transition of human walking. IEEE Int Conf Rehabil Robot (2013) 0.75
Hypoxia-inducible factor-1α G polymorphism and the risk of cancer: a meta-analysis. Tumori (2015) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75
Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer. Hum Genet (2004) 0.75